4,145
Views
24
CrossRef citations to date
0
Altmetric
Report

Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors

, , , , , , , , , , , , , , , , , , , , & show all
Pages 104-117 | Received 14 Aug 2017, Accepted 22 Sep 2017, Published online: 24 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Richa Mishra, Lalita Mohan Behera & Soumendra Rana. (2022) Binding of raloxifene to human complement fragment 5a (hC5a): a perspective on cytokine storm and COVID19. Journal of Biomolecular Structure and Dynamics 40:3, pages 982-994.
Read now

Articles from other publishers (23)

Stefan E. Sonderegger, Silvia Manzanero, Trent M. Woodruff, Jad Farouqa, Jamileh Nabizadeh, Nadya Panagides & Barbara E. Rolfe. 2024. Clinical Immuno-Oncology. Clinical Immuno-Oncology 41 60.e10 .
Yiqing Feng, Sidney Liang, Jonathan Langille, Betsy S. Pierce, SeungWon Chung, Jan Szeliga, Glenn Wilcox, Paul Simonds, Kathleen A. Farley, Bryan Li, Carmen Garcia-Irizarry, Peter Jones & Ricardo Lira. (2023) Improved Synthesis of a Macrocyclic Peptide-Like C5aR Antagonist for Intravenous Applications. Organic Process Research & Development 27:11, pages 2010-2019.
Crossref
Manish K. Yadav, Jagannath Maharana, Ravi Yadav, Shirsha Saha, Parishmita Sarma, Chahat Soni, Vinay Singh, Sayantan Saha, Manisankar Ganguly, Xaria X. Li, Samanwita Mohapatra, Sudha Mishra, Htet A. Khant, Mohamed Chami, Trent M. Woodruff, Ramanuj Banerjee, Arun K. Shukla & Cornelius Gati. (2023) Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors. Cell 186:22, pages 4956-4973.e21.
Crossref
Baohong Xu, Hang Su, Changjun Chen, Qiaolin Liu, Tiaoyi Xiao, Yi Liu, Zhao Lv, Hongquan Wang & Zheyu Wen. (2023) Pro-inflammatory regulatory mechanism of C5a/C5aR pathway in GCRV-infected grass carp (Ctenopharyngodon idella). Aquaculture Reports 32, pages 101736.
Crossref
Manaswini Ghosh & Soumendra Rana. (2023) The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics. International Immunopharmacology 118, pages 110081.
Crossref
Xinfeng Zhao, Qian Li, Jing Wang, Qi Liang & Jia QuanXinfeng Zhao, Qian Li, Jing Wang, Qi Liang & Jia Quan. 2023. G Protein-Coupled Receptors. G Protein-Coupled Receptors 1 28 .
Aurosikha Das, Pulkit K. Gupta & Soumendra Rana. (2022) C5aR2 receptor: The genomic twin of the flamboyant C5aR1. Journal of Cellular Biochemistry 123:11, pages 1841-1856.
Crossref
Karnpob Kanhasut, Kannan Tharakaraman, Mathuros Ruchirawat, Jutamaad Satayavivad, Mayuree Fuangthong & Ram Sasisekharan. (2022) Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking. Scientific Reports 12:1.
Crossref
Michael BauerAndreas WeylandGernot MarxFrank BloosStephan WeberNorbert WeilerStefan KlugeAnja DiersTim Philipp SimonIngmar LautenschlägerMatthias GründlingUlrich JaschinskiPhilipp SimonAxel NierhausOnnen MoererLorenz ReillAchim JörresRenfeng GuoMarkus LoefflerKonrad ReinhartNiels Riedemann. (2021) Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study). Critical Care Explorations 3:11, pages e0577.
Crossref
Aurosikha Das, Lalita Mohan Behera & Soumendra Rana. (2021) Interaction of Human C5a with the Major Peptide Fragments of C5aR1: Direct Evidence in Support of “Two-Site” Binding Paradigm. ACS Omega 6:35, pages 22876-22887.
Crossref
Sandor Vajda, Kathryn A Porter & Dima Kozakov. (2021) Progress toward improved understanding of antibody maturation. Current Opinion in Structural Biology 67, pages 226-231.
Crossref
Peter W. West, Rajia Bahri, Karen M. Garcia-Rodriguez, Georgia Sweetland, Georgia Wileman, Rajesh Shah, Angeles Montero, Laura Rapley & Silvia Bulfone-Paus. (2021) Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins. Frontiers in Immunology 11.
Crossref
Angelino T. Tromp, Yuxi Zhao, Ilse Jongerius, Erik C. J. M. Heezius, Pauline Abrial, Maartje Ruyken, Jos A. G. van Strijp, Carla J. C. de Haas, András N. Spaan, Kok P. M. van Kessel, Thomas Henry & Pieter-Jan A. Haas. (2020) Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein. Disease Models & Mechanisms 13:9.
Crossref
Min Hu, Guangbo Kang, Xin Cheng, Jiewen Wang, Ruowei Li, Zixuan Bai, Dong Yang & He Huang. (2020) In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabody. Biochemical and Biophysical Research Communications 529:4, pages 936-942.
Crossref
Ting Zhang, Kun-yi Wu, Ning Ma, Ling-lin Wei, Malgorzata Garstka, Wuding Zhou & Ke Li. (2020) The C5a/C5aR2 axis promotes renal inflammation and tissue damage. JCI Insight 5:7.
Crossref
Longxin Chen, Chaoyang Zhu, Hui Guo, Runting Li, Limeng ZhangZhenzhen XingYue SongZihan ZhangFuping WangXiaofeng LiuYuhan ZhangRunlin Z. MaFeng Wang. (2020) Epitope-directed antibody selection by site-specific photocrosslinking. Science Advances 6:14.
Crossref
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Jakub Luptak, Michal Bista, David Fisher, Liz Flavell, Ning Gao, Kate Wickson, Steven L. Kazmirski, Tina Howard, Philip B. Rawlins & David Hargreaves. (2019) Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallographica Section D Structural Biology 75:11, pages 1003-1014.
Crossref
Richa Mishra & Soumendra Rana. (2019) A rational search for discovering potential neutraligands of human complement fragment 5a (hC5a). Bioorganic & Medicinal Chemistry 27:19, pages 115052.
Crossref
Daniel A. Cannon, Lu Shan, Qun Du, Lena Shirinian, Keith W. Rickert, Kim L. Rosenthal, Martin Korade, Lilian E. van Vlerken-Ysla, Andrew Buchanan, Tristan J. Vaughan, Melissa M. Damschroder & Bojana Popovic. (2019) Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design. PLOS Computational Biology 15:5, pages e1006980.
Crossref
Yuanyuan Ma, Yanqun Liu, Zhijun Zhang & Guo-Yuan Yang. (2019) Significance of Complement System in Ischemic Stroke: A Comprehensive Review. Aging and disease 10:2, pages 429.
Crossref
Wang Yuxuan. (2019) Important roles of C5a and C5aR in tumor development and cancer treatment. E3S Web of Conferences 136, pages 06012.
Crossref
Chao Hu, Long Li, Peipei Ding, Ling Li, Xiaowen Ge, Long Zheng, Xuanchuan Wang, Jina Wang, Weitao Zhang, Na Wang, Hongyu Gu, Fan Zhong, Ming Xu, Ruiming Rong, Tongyu Zhu & Weiguo Hu. (2018) Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling. The Journal of Immunology 201:12, pages 3717-3730.
Crossref